(Sharecast News) - MaxCyte announced a strategic collaboration with Ori Biotech on Wednesday, to improve the efficiency and scalability of cell therapy manufacturing, integrating its 'Flow Electroporation' technology with Ori's next-generation 'IRO' manufacturing platform.
The AIM-traded firm said the partnership would focus on evaluating how Ori's IRO system could enhance yield...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE